GlassScriptPhysician profile
Ivo A Baux
NPI 1114937356
$1,618.62
in general payments reported to CMS, 2019-2025
10 companies · $1,254 in 2025
The $1,254 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.66 · 2020: $59.43 · 2021: $16.47 · 2022: $189 · 2023: $26.46 · 2024: $60.54 · 2025: $1,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $794 · Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $794.43 |
| Food and Beverage | $546.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,018.38 | 2024-2025 | Triclip, Mitraclip, Epic |
| Abiomed | $145.66 | 2025 | |
| Acacia Pharma INC | $94.34 | 2022 | |
| Csl Behring | $77.93 | 2022-2023 | Kcentra |
| Chiesi USA, INC. | $65.61 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $57.38 | 2024-2025 | Bridion |
| Atricure, INC. | $56.10 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Cumberland Pharmaceuticals, INC. | $39.09 | 2019-2020 | |
| Mindray Ds USA, INC. | $36.87 | 2025 | Te7 Max, Te X |
| Getinge USA Sales, LLC | $27.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivo Baux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.